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After infection with unrelated viruses such as paramyxoviruses, orthomyxoviruses, 
poxviruses, and rhabdoviruses (1) mice generate cytolytic T  lymphocytes (CTL) 1 that 
possess  selective specificity  for  the  sensitizing  virus.  However,  after  infection  with 
different subtypes of serologically distinct  influenza A  viruses (2)  at least more than 
one population of CTL can be demonstrated. Both cross-reactive and subtype-specific 
lymphocytes can be distinguished  (3-12). 
These  cross-reactive  effector  T  ceils  may  lack  the  discriminatory  capacity  for 
influenza  antigens  shown  by the  B  cell  products,  or  they  may recognize  a  shared 
antigenic determinant.  Because the question of the nature of antigens recognized by 
T  cells, as well as the structure and composition of the T  cell receptor, is not yet clear, 
the  orthomyxoviruses  offer a  biological  relevant  system  for  the  analysis  of T  cell 
specificity. 
The subtypes of influenza  A  viruses differ with respect  to the antigenicity  of the 
envelope glycoproteins, hemagglutinin  (HA) and neuraminidase  (N). HA and N  are 
inserted into the plasma membrane of cells during the budding process that results in 
virus  release  from  the  infected  cells  (13,  14).  The  internal  virion  components,  the 
matrix (M) protein and the ribonucleoprotein (NP), of all influenza A viruses seem to 
be  closely  related  antigenically.  The  cell-membrane  expression  of  antigens  is  a 
prerequisite for T  cell recognition  (15-17). The work of several authors has therefore 
centered  on the question  of membrane expression of these antigens.  M  protein  has 
now been detected on the cell membrane, and, consequently, it has been claimed that 
the cross-reactive T  cell may recognize this protein (8,  18-22). 
This study aims to clarify the role of M  protein in the CTL response. Target cells 
were prepared  by two different  methods.  First  by abortive infection  of L-929  cells 
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with an avian influenza A  strain that expresses only the viral envelope glycoproteins, 
HA and N, in the plasma membrane (23). Second, the HA and N  glycoprotein of the 
human  influenza virus A/Victoria were separated from the other virion components 
and reconstituted into artificial lipid bilayers (24, 25) to give vesicles free of M  protein 
and NP. Target cells were then prepared by incubating these vesicles with cells in the 
presence of fusion-active Sendai  virus  (26).  Various  influenza A-specific CTL  were 
tested against both types of target cells. The results showed a similar pattern of cross- 
reactivity with that previously observed after infection of cells with different human 
influenza A  virus subtypes. Thus  target  antigens recognized by cross-reactive CTL 
are  not  carried  by  M  protein  but  by  the  glycoproteins  HA  or  N  in  the  plasma 
membrane. 
Materials  and  Methods 
Viruses.  Sendai virus; the influenza viruses A/Asia/M/1468 (H2N2), A/PR/8/34 (HON1), 
A/Victoria/3/75 (H3N2),  and B/Mass/71;  and the avian influenza strains A/FPV/Rostock 
(Havl/Nl)  and  A/Tur/Canada/63  (Hav6  Neq2)  were  used.  Viruses  were  grown  in  the 
allantoic cavity of  11-d-old embryonated chicken eggs, and  virus stocks were stored in  the 
allantoic fluid at -80°C. Plaque assays for the determination of plaque-forming units (PFU), 
titration of hemagglutinating units  (HAU),  N  and  hemolytic activities were carried out  by 
established procedures (15). 
Purification of Sendai virus (SV), inactivation with fl-propiolactone, and digestion of trypsin- 
inactivated SV (TRY-SV) to destroy the functional activity of the fusion protein were done as 
described previously (15,  17). 
Preparation of Influenza A  Glycoprotein and Reconstitution  into Artificial  Vesicles.  Purified influenza 
A/Victoria was a gift from Searle Laboratories, London. Virus protein was determined by the 
Lowry method using bovine serum albumin standards. Influenza A/Victoria virus (10 mg/ml) 
was  suspended  in  phosphate-buffered saline  (PBS),  without  Mg or Ca,  that  contained  2% 
Empigen BB (Albright & Wilson Ltd., Detergents and Chemical Group, Whitehaven, England) 
and I mM phenylmethylsulfonylfluoride (PMSF) (Sigma Chemical Co., London). Preparation 
of tritium-labeled virus was carried out according to the method of Critchley (27).  Disruption 
of virus and solubilization of glycoproteins was achieve  d by three separate 15-s sonications at 
setting 3 with a Branson sonicator probe (model 2530-IA, Branson Sonic Power Co., Danbury, 
Conn.)  at 4°C. The disrupted virus was dialyzed overnight against  1 M  Tris buffer (pH 6.8) 
that contained 2% Empigen BB,  1 mM PMSF, and  100 mM sodium azide. The preparation 
(25 mg unlabeled virus in 4 ml and 200/~g of tritium-labeled virus) was then layered onto a 
sucrose gradient that consisted of three zones similar to that described by Helenius et al. (24): 
A 2°ml 10% sucrose zone that contained 2% Empigen BB on top, a 30-ml linear 15-30% sucrose 
gradient  that  contained  1%  Empigen  BB  in  the  middle, and  a  2-ml  50%  (wt/vol)  sucrose 
cushion in Tris-buffered saline (TN') buffer (pH 7.4) at the bottom. 
After  centrifugation  (40  h,  4°C,  25,000  rpm)  in  a  Beckman  SW  27  rotor  (Beckman 
Instruments Inc., Spinco Div., Palo Alto, Calif.), fractions were collected from the bottom and 
assayed for  radioactivity and  protein concentration.  The  protein-containing fractions were 
analyzed by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis by the method of 
Laemmli (28) with 10% gels. Two-dimensional gel electrophoresis was carried out according to 
the method of Wang and Richards (29).  Fractions that contained only the envelope glycopro- 
teins were used for reconstitution. Reconstitution was done according to a protocol developed 
for reconstitution of SV envelope proteins (M.-J. Gething. Unpublished observations.): The 
lipids L-phosphatidyl-c-serine (PS)  (10 mg/ml) (Sigma Chemical Co.); phosphatidylethanola- 
mine (PE)  (1  mg/ml)  (BDH Chemicals Ltd., Poole, England); phosphatidylcholine (PC)  (10 
mg/ml) (Sigma Chemical Co.); and cholesterol (Chol) (I0 mg/ml) (Sigma Chemical Co.) that 
were suspended in chloroform:methanol 95:5  (vol/vol) were used. Lipids were mixed in the 
ratio  of 2  PE:I  PS:I  PC:I  Chol  in  30-ml  tubes,  and  the  chloroform  and  methanol  were 
evaporated under nitrogen, washed  twice with  the same volume of diethylether, and  dried 
under nitrogen to obtain a thin lipid film. The film was dissolved in TN buffer that contained KOSZINOWSKI, ALLEN,  GETHING, WATERFIELD, AND  KLENK  947 
1 mM PMSF, 2 mM CaCl2, 2 mM MgCI2, and  1% Empigen BB by heating for 30 s at  100°C. 
The detergent-purified HA and N viral glycoproteins in TN buffer that contained 1% Empigen 
BB  were added. Reeonstitution was achieved by detergent dilution (24).  The detergent was 
diluted by stepwise addition of TN buffer over a  period of 5 h. A control preparation of HA 
and N was also made without lipid. The reconstituted HA and N vesicles were concentrated by 
centrifugation (15 h, 20°C, 38,000 rpm, 8- ×  50-ml MSE Rotor, MSE Scientific Instruments, 
Manor  Royal,  Crawley,  Sussex,  England).  The  pellet  was  resuspended  in  TN  buffer  and 
analyzed by polyacrylamide gel electrophoresis and electron microscopy. 
Mice.  Female C3H (H-2K), CBA/J (H-2K), C3HOH (H-2°), and DBA/2/Den (H-2  d) mice 
were bred at the German Cancer Research Center, Heidelberg, Federal Republic of Germany 
or purchased from Ry Bomhohgard, Copenhagen, Denmark, and used at 8-12 wk of age. Mice 
were immunized by single inoculation of 200-400 HAU i.p. of virus. Effector-cell generation by 
secondary challenge with homologous virus in vitro was done as described previously (15,  17, 
30, 31).  Spleen cells from mice primed 3-6 wk before testing were cultured in the presence of 
stimulator cells  at  a  ratio  of  10:1 for  5-7  d  in  RPMI-1640  medium  supplemented  with 
antibiotics, 2 ×  10 -6 M  2-mercaptoethanol, and  10% heat-inactivated fetal calf serum (Grand 
Island Biological Co., Grand Island, N. Y.). Stimulator cells were prepared by incubation of 
syngeneic spleen cells with  1-10  HAU of virus/106 cells for 60  min  followed by a  threefold 
washing of cells. 
Cytolytic Assay.  P-815 (H-2  d) and L-929 (H-2  k) cells were grown in tissue culture. For target- 
cell formation with influenza viruses, 108 cells were incubated either with 200 HAU of virus or 
with preparations that contained known amounts of PFU. After 60 min, virus adsorption cells 
were washed three times and labeled with 51Cr for a  further 3 h. Target cells prepared with 
inactivated SV and TRY-SV were obtained as described before (17). Preparation of target cells 
with vesicles was carried out as previously described (26): Influenza vesicles were bound to cells 
by incubation of 106 cells with 30 #g of vesicles for 4  h.  F/asion of influenza A  vesicles that 
contained HA and N was achieved by coincubation of cells with 30/tg of vesicles and  10 p.g of 
fusion-active SV for 4 h. A control for fusion was carried out with the same amount of TRY- 
SV. In the cytolytic assay, target cells were incubated with CTL at four effector:target ratios. 
After a  4-h  incubation at  37°C  in  5%  CO~ atmosphere, supernates were harvested and  the 
specific release was determined as percent specific 61Cr release =  (release by effector cells - 
spontaneous release/maximal release -  spontaneous release) X  100. Spontaneous release was 
determined from target cells incubated with medium only, and maximal release from target 
cells incubated with 2% SDS in PBS. All values are the mean percent specific SlCr release of at 
[east three wells. 
Results 
Abortively Infected Targets Devoid of M  Protein Are Lysed by Cross-Reactive CTL.  In  L- 
929 cells infected with influenza A/fowl plague virus (FPV) the synthesis of M  protein 
does not  occur, although  the virus-specific glycoproteins are synthesized and  incor- 
porated into the plasma membrane  (23). This system was used to determine the role 
of the M  protein as an antigen recognized by cross-reactive influenza A  strain-specific 
CTL.  L-929  target  cells infected with  10  PFU/cell of A/FPV  were  incubated  with 
secondary CTL of CBA mice sensitized in vivo and restimulated in vitro with FPV, 
A/Asia, PR/8,  A/Turkey, or B/Mass.  As expected, lysis was  seen after addition of 
effector cells that had specificity for FPV (Fig.  1). However, the all-influenza-type-A- 
primed effector cells in addition to the effect on homologous targets also lysed the L- 
929  target  cells infected with  FPV.  Only effector cells with  specificity for  B/Mass 
failed to lyse the  L-929  FPV  targets.  This  pattern  of cross-reactivity that  has  been 
observed by other authors  (3,  5,  7,  9)  was also found when  influenza A  target cells 
that lacked M  protein were used. 
To exclude involvement of M  protein from  the virions used  for cell infection, the 
following  experiment  was  carried  out:  L-929  cells  were  infected  with  FPV  at  a 948  VIRAL  GLYCOPROTEIN  RECOGNITION  BY  CROSS-REACTIVE  T  CELLS 
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Flo.  1.  Effect of influenza subtype-specific CTL on L-929 target cells abortively infected with 10 
PFU/FPV cell. CTL were primed and restimulated with the homologous virus strain and tested on 
target cells  infected with the sensitizing virus or with FPV.  Target cells:  (O)  noninfected L-929; 
(O)  L-929 infected with A/FPV;  ([3)  L-929 infected with A/Turkey;  (I)  L-929 infected with A/ 
Asia; (A) L-929 infected with A/PR/8;  (A) L-929 infected with B/Mass. 
multiplicity  of  infection  (MOI)  of 0.01-100  PFU/cell  and  tested  after  a  4-h  or 
overnight  incubation  after  infection.  Effector  cells  were  secondary  C3H.OH  CTL 
with  specificity  for A/Asia.  Fig.  2  shows that  the same cross-reactivity pattern  was 
observed at  the MOI  of 1 PFU/ceI1,  which  is too low to obtain lysable  target  cells 
after 4 h of infection, and 16 h of synthesis of viral glycoproteins is required for T  cell- 
mediated  lysis.  Therefore, the M  protein  transported into the target cell  during the 
process of penetration can not explain the cross-reactivity observed. 
Reconstitution of Membrane  Glycoproteins HA  and  N  in  Lipid  Vesicles.  Influenza A/ 
Victoria virus was solubilized  by  sonication  in  detergent.  The solubilized  virus was 
centrifuged into a sucrose gradient  in detergent. The spike proteins, HA and N, were 
recovered as a broad band in the upper part of the gradient;  whereas NP was found 
in  the  bottom  fractions  and  M  protein  and  lipids  at  the  top  of the  gradient.  The 
fractions were analyzed by polyacrylamide gel electrophoresis, and the composition of 
the fractions used  for reconstitution is shown in  Fig.  3 A  and B.  It  is shown in two- 
dimensional gel that the high molecular proteins on the top of the gels contain trimers 
and dimers of HA as well as N, but no NP or M  protein. 
Lipid-free  HA  and  N  will  not  interact  with cells  to produce lysable  targets  (26), 
presumably  because these  integral  viral  membrane proteins are no longer correctly 
orientated  in  a  lipid  bilayer.  To  mimic  the  normal  mode of presentation  of these 
glycoproteins, the HA and N  were reconstituted in lipid  vesicles and integrated  into 
the target cell membrane obtained by fusion. 
The  lipids  PE,  PS,  PC,  and  Chol  were  solubilized  in  the  detergent-solubilized 
proteins. The detergent concentration was reduced -50-fold by stepwise dilution. The 
reconstituted material was analyzed by electron microscopy. The glycoproteins were KOSZINOWSKI,  ALLEN,  GETHING,  WATERFIELD,  AND  KLENK  949 
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FIG.  2.  Effect ot'virus concentration and viral protein zynthesis on antigen formation recognized 
by cross-reactive CTL.  Effector cells were C3H.OH  lymphocytes primed in vivo and restimulated 
in vitro with A/Asia. Target cells were prepared by incubation of L-929 cells with different PFU/ 
cell (number of PFU shown in each box) for (1) 4 b or (0)  16 h. CO, uninfected targets. 
FIG.  3.  (A) Polyacrylamide gel electrophoresis in SDS under nonreduced conditions of A/Victoria 
virus proteins, after gradient centrifugation and after reconstitution. Left lane:  A/Victoria virus; 
middle lane:  fraction with peak radioactivity and glycoprotein concentration; right lane: reconsti- 
tuted preparation. (B) Two-dimensional gel of A/Victoria virus proteins. First dimension: Laemmli 
tube  gel  (5%  stack,  10%  running gels).  Second  dimension:  under  reduced conditions performed 
according to Wang and Richards (29). After splitting by reductive cleavage during the initial phase 
of the second-dimension slab gel, the molecule complexes are identified by their off-diagonal position 
on the final pattern.  (HA)h HA monomers; (HA)2, HA dimers; (HA)~,  HA trimers. 950  VIRAL GLYCOPROTEIN  RECOGNITION  BY  CROSS-REACTIVE T  CELLS 
Fzo. 4.  Electronmicroscopy of reconstituted vesicles. Y 120,000. 
observed as  distinct spikes,  the  majority of which  were  associated with  unilamellar 
vesicles that  ranged  in  size from  10  to  50  nM  (Fig. 4).  Some  vesicles were  round or 
oval, whereas others were extended and  irregular but  enclosed by a  lipid bilayer. A 
background of what  are probably free spikes or rosettes of lipid-free spikes was also 
seen.  The  packing  of spikes was  similar  to  that  observed  on  virus  particles and  it 
appeared  that  the  spikes were orientated  so that  they projected outwards  from  the 
lipid bilayer. This outward orientation is supported by the observation that reconsti- 
tuted  vesicles showed  10-  to  100-fold  greater hemagglutinating  activity than  glyco- KOSZINOWSKI,  ALLEN,  GETHING,  WATERFIELD,  AND  KLENK  951 
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FIG.  5.  Target cell  formation  with  influenza envelope proteins reconstituted  into  lipid  vesicles. 
Target cells were prepared by incubation of 106 L-929 cells with 10 #g fl-propiolactone-inactivated 
SV, with  10/.tg SV with enzymatically inactivated fusion protein  (TRY-SV),  100  HAU influenza 
A/Victoria,  30 /~g reconstituted  envelope proteins of A/Victoria-virus  vesicles (A/VIC-VES),  or 
with mixtures of reconstituted vesicles with SV preparations. Incubation time of cells with virus was 
4 h at 37°C. Targets were incubated with effector ceils with specificity for either SV or influenza A/ 
Victoria (A/VIC). 
proteins  that  were  carried  through  the  reconstitution  procedure  in  the  absence  of 
lipid.  Such preparations contained rosettes and free glycoprotein spikes with no sign 
of vesicle formation (data not shown). 
Target-Cell  Formation  with  Influenza  A/Victoria  Glycoproteins  Incorporated  into 
Vesicles.  Although vesicles  that contain HA and N  attach to target cells,  fusion does 
not seem to occur. Thus we have used a recently developed method to prepare target 
cells  with  reconstituted  Semliki  forest  virus  membrane  vesicles  (26).  Influenza A/ 
Victoria  vesicles  were  incubated  with  51Cr-labeled  L-929  cells  in  the  absence  or 
presence of noninfectious fl-propiolactone-treated, fusion-active SV or TRY-SV that 
was no longer capable of causing fusion. As control targets, noninfected L-929 cells, 
L-929 cells infected with influenza A/Victoria, or L-929 cells  incubated with the two 
preparations of SV were used.  Antigen-specific T  cell-mediated cytolysis was tested 
by the addition to these targets of either  SV-specific CTL or influenza A/Victoria- 
specific CTL  (Fig.  5).  Target  cells  prepared  with  TRY-SV were  not susceptible  to 
lysis,  presumably as a  result  of the loss of fusion activity (17).  Similarly,  the targets 
incubated with influenza A/Victoria vesicles alone or together with TRY-SV showed 
a  low level  of lysis,  which  indicated  that  the  mere  presence of SV  antigens  is  not 
sufficient  to  form  influenza-specific target  cells  with  vesicles.  However,  target  cells 
incubated with  the vesicles  and  fusion-active SV were  lysed by both the influenza- 
specific CTL and the SV-specific CTL. The specificity of influenza A/Victoria CTL 
in this reaction is selectively directed to influenza A/Victoria antigens, and there is no 
evidence to support the idea that  SV antigens are recognized by these effector ceils. 952  VIRAL  GLYCOPROTEIN  RECOGNITION  BY  CROSS-REACTIVE  T  CELLS 
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Fro.  6.  Cytolytic  activity  of  various  influenza-  and  V-specific  CTL  on  artificial  target  cells 
prepared with reconstituted virosomes. Target  L-929 cells incubated with (O)  A/Victoria-vesicles 
and SV (Fig. 5 legend); (A) A/Victoria; (11) FPV; (V) A/Asia; (0) A/PR/8; (~) B/Mass.; (ZX) SV; 
(O) noninfected L-929 control. 
Cross-Reactive CTL Specific for Different  Subtypes of Influenza  A  Recognize Antzgens of the 
Influenza  A~ Victoria Envelope Proteins.  Having established a method to test target cells 
prepared with  the envelope proteins, a  variety of effector cells specific for different 
influenza  subtypes were tested.  CTL with  specificity for FPV,  A/Asia,  A/PR8,  A/ 
Victoria, and B/Mass. were tested on targets infected with homologous or heterologous 
virus or on targets prepared with reconstituted  vesicles that contained only the HA 
and N glycoproteins of A/Victoria. Target cells incubated with SV served as a control. 
The results are shown in  Fig.  6. There was no cross-reactivity between influenza A- 
and influenza B-specific effector cells. Specific lysis was demonstrated on the homol- 
ogous  targets  and  cross-reactive lysis to  various  degrees  on  the  heterologous  target 
cells.  Effector  cells  that  showed  cross-reactivity  for  target  cells  infected  with  A/ 
Victoria  also  produced  significant  lysis of target  cells  prepared  with  reconstituted 
vesicles that contained only the HA and N  glycoproteins. Thus, antigen recognition 
by cross-reactive T  cells is independent of the presence of M  protein. 
Lysis  of Artificial  Target  Cells  is  H-2  Restricted.  To  confirm  the  observation  that 
recognition of the artificial  target cells is  mediated  by processes similar to those of 
targets prepared by infection the H-2 restriction of the cytolytic interaction was tested. 
Effector cells of the haplotypes H-2  b and H-2  k were tested on the appropriate target 
cells as well as on artificial cells prepared by fusion with A/Victoria vesicles. Table I 
shows  that  the  H-2-restriction  rule  also  applies, to  the  target  cells  prepared  with 
artificial vesicles. 
Discussion 
The  aim  of  this  study  was  to  define  the  molecules  that  carry  the  specificities 
recognized  by cross-reactive CTL  that  lyse  target  cells  infected  with  serologically 
different influenza A  subtypes. By using two types of target cells, both devoid of M 
protein,  we  found  that  cross-reactive  T  cells  recognize  antigens  of  the  envelope KOSZINOWSKI,  ALLEN,  GETHING,  WATERFIELD,  AND  KLENK 
TABLE  I 
H-2 Restriction of Cross-Reactivity Against  Target Cells Prepared with A/ 
Victoria Virus Vesicles 
Target 
Effector cell  P-815-A/  L-929-A/  L-929-A/ 
P-815-A/  Vic-ves  +  Vic-ves + 
Asia  Asia  SV*  SV 
% 
DBA/2-A/Asia  68.5  32.6  3.2  4.8 
CBA-A/Asia  4.3  5.6  45.4  22.3 
Effector cells are derived  from spleen cells of mice primed with A/Asia and 
restimulated in vitro for 6  d  with A/Asia-infected syngeneic stimulator cells. 
The effector:target ratio was 25:1. 
* Vic-ves, A/Victoria virus vesicles. 
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glycoproteins HA and N  of influenza A  viruses. This is in contrast to previous work 
that  indicated  a  major  role  for  M  protein  in  providing  the  cross-reactive  target 
antigen. 
M  protein, which is antigenically similar in all influenza A strains, was considered 
to be the candidate for the cross-reactive antigen seen by these T  cells because recent 
studies  have  demonstrated  that  the  M  protein  may be detected  on ~the surface  of 
infected cells (18-21).  Braciale (8)  has investigated the M  protein specificity of CTL 
by  interfering  with  the  process  of glycosylation.  By  showing  that  2-deoxyglucose 
treatment of target cells had  (a)  no effect on M  protein expression and  (b)  changed 
the competition pattern of cold target cells infected with homologous or heterologous 
influenza A subtypes, he concluded that the cross-reactive target antigen is a nongly- 
cosylated protein and, therefore, perhaps, the M  protein. However, the role of protein 
glycosylation  for  the  target  antigen  recognition  by  CTL  is  unknown,  and  these 
conditions  still  allow  HA  synthesis  of  various  degrees  of  glycosylation  (32,  33). 
Furthermore, 2-deoxyglucose has profound inhibitory effects on T  cell-mediated lysis 
(34). 
We  first  investigated  the  role  of M  protein  in  determining  the  pattern  of cross- 
reactivity in abortively infected cells. By abortive infection of L-929 cells with avian 
influenza A  strains  (FPV),  target cells could  be prepared that  carry exclusively the 
HA and N  proteins of influenza virus in their plasma membranes and are devoid of 
the  M  protein  (23).  These cells were used  as targets  for influenza  A-specific CTL. 
When the two influenza-specific effector-cell subsets were tested on these target cells, 
the same pattern of cross-reactivity could be observed as had been found with target 
cells prepared with other influenza A strains. These results strongly argue against the 
role of M  protein as a major antigen for cross-reactive T  cell populations and indicate 
that  these effector cells recognize antigens  present on the HA and  N  glycoproteins. 
However, it remains possible that a low level of synthesis of M  protein that we cannot 
detect occurs in these cells or that other components of the influenza virion may serve 
as target antigens. 
With respect to the HA specificity of effector cells and the process of cross-reactivity, 
controversy exists with regard to the use of productively vs. abortively infected target 
cells (22, 35, 36).  In some cases it has been suggested that incorporation of M  protein 
into the plasma membrane of cells is even higher in abortively than in productively 954  VIRAL  GLYCOPROTEIN RECOGNITION BY CROSS-REACTIVE T  CELLS 
infected cells  (8,  20-22,  35-37).  However, the opposite situation  has been  demon- 
strated  in  the  model  of the  FPV  infection of L-929 cells  (23).  Perhaps  the  major 
difference between the results obtained by different authors is a result of the different 
test  conditions;  for example,  short-  vs.  long-term  cytolytic assay  and  primary  vs. 
secondary CTL. 
Further evidence for the concept that the envelope glycoproteins carry the target 
antigens recognized by the cross-reactive T  cell subset has been provided by target 
cells  that  carry  the  spike  proteins  of influenza  virus  exclusively and  none  of the 
influenza internal virion components. The preparation of those artificial target cells 
requires separation of the envelope proteins from the other viral components, recon- 
stitution  of the  envelope proteins  into  lipid  bilayers, and  fusion of these  artificial 
vesicles with the plasma membrane to generate target cells lysable by immune effector 
mechanisms  (26). Preparation of pure envelope proteins from influenza virus strain 
A/Victoria  was  achieved  after disruption  of the  virions  in  detergent  followed by 
separation of the proteins on a sucrose gradient. For reconstitution of the detergent- 
solubilized proteins into lipid vesicles a  mixture of four different phospholipids was 
used, and vesicle formation was achieved by a detergent-dilution procedure. 
Reconstituted vesicles were smaller than virions. The packing of spikes in the lipid 
bilayer was found to be very compact by electron microscopy (EM). The ratio of HA: 
N  spikes  observed by EM  was  similar  to  that  of the  virus  (38).  These artificially 
reconstituted  vesicles bind  to  the  cell  surface  as  revealed  by  immunofluorescence 
studies (data not shown). However, they do not fuse to any significant extent with the 
plasma membrane as cytolytic tests with antibody and complement (data not shown) 
and with cytolytic T  cells were negative. 
Vesicle-cell fusion can be achieved with polyethylene glycol (U. H. Koszinowski. 
Unpublished  observations.).  However, this  method  was  poorly reproducible,  and, 
thus, fl-propiolactone-inactivated SV was used to promote fusion. This method offers 
some advantages. The fusion of SV with the cell membrane and its function in cell- 
cell fusion requires the presence of a  functionally active fusion protein (16,  17). The 
fusion by SV can be monitored by the activity of SV-specific effector cells that are 
(a)  selectively specific for SV and  do not  recognize influenza antigens  and  (b)  also 
require the plasma  membrane insertion of the SV antigens to lyse their targets.  By 
using (a) two types of effector cells, one specific for SV and the other for influenza A 
antigens, and (b) target cells prepared either by infection with influenza A virus or by 
incubation with vesicles or mixtures of vesicles and  fusion-active or fusion-inactive 
SV, the experimental system could be controlled for both antigenic specificities and 
for  fusion.  The  molecular  mechanism(s)  responsible  for  fusion  between  the  virus 
envelope  and  the  plasma  membrane  and  subsequent  fusion  between  the  plasma 
membranes  and  adjacent  cells  (or adjacent  vesicles)  in  fusion  from without  is  still 
unknown (39).  In this study we have not tried to visualize the process of fusion itself. 
Therefore, the interpretation of the results as a result of fusion is based on the present 
knowledge about  the  conditions  under which  virus-induced cell  fusion  does occur 
(40). 
Target cells prepared in this way were susceptible to the lysis of CTL specific for 
the  homologous influenza  A  strain  and  for CTL with  specificity for heterologous 
influenza A  strains.  The absence of M  protein in  the vesicles provided the  formal 
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protein. Therefore, the nature of the antigens seen by this cell population must  be 
solely a result of the antigens of the influenza HA and N glycoproteins. Although our 
preparations contained far more HA than N glycoproteins, we have not yet determined 
to  which  extent  both  envelope proteins  contribute  to  the  cross-reactive antigenic 
specificity. Work is in progress to prepare vesicles that contain either the HA or the 
N. Studies on the primary structure of the HA glycoprotein of different subtypes have 
made  it  possible  to  distinguish  regions  of variable  and  of conserved amino  acid 
sequence.  Thus  it  is  quite  possible  for  the  HA  to  present  a  common  structural 
determinant that could be recognized by cross-reactive T  cells.  It is also possible that 
the N, which is known to show much less antigenic variation, may carry a  common 
determinant  (41).  Cross-reactivity of effector cells is also in accord with the observa- 
tions of heterotypic immunity (10, 42, 43). 
Recent  data  indicate  that  the  specificity of CTL  directed  to  influenza  A  virus 
antigens can be manipulated by different in vitro restimulation methods. With virions 
of heterologous strains as antigen for restimulation in vitro, the cross-reactive popu- 
lations  are  predominantIly  triggered  (4),  whereas  restimulation  with  homologous 
purified HA raises CTL with specificity for the viral HA (6, 44). If one assumes that 
in both cases determinants are recognized that are carried by the envelope proteins, 
the preparation of the antigens as either solubilized spikes or as proteins integrated 
and orientated in the cell membrane may decide which T  cell population is triggered. 
The observation of cross-reactivity at the T  cell level, which seems not to be reflected 
at the B cell level, is not without precedent (45, 46). Furthermore, the hypothetical M 
protein specificity of T  cells also lacks an explanation because a  primary influenza 
infection does not normally cause a  significant antibody response to the M  protein 
(2). 
In  assuming  that  the  cross-reactive  CTL  are  not  less  specific  but  recognize  a 
common antigen shared by the glycoproteins, several explanations can be forwarded: 
(a) The number of B cell clonotypes (47, 48) to the cross-reactive antigens is normally 
too  small  to  be  detected.  (b)  The  appropriate  determinant  cannot  be  selected  by 
antigen-presenting cells for T  ceils that  help B cells  (49).  (c) The B cell response to 
these antigens is normally suppressed (50). If the possibilities b and/or c do apply, one 
could predict that  sensitization with inactivated or purified virions or viral protein 
preparations should give rise to similarly cross-reactive B cell clones. The preparation 
of defined molecules and their artificial integration in the plasma membrane may be 
a useful tool for the further analysis of T  cell specificity. 
Summary 
Two populations  of cytolytic T  lymphocytes (CTL)  generated after influenza A 
virus  infection  can  be  distinguished  into  one  with  specificity  for  the  sensitizing 
hemagglutinin type and a second with cross-reactivity for antigens induced by other 
type-A influenza viruses. The molecules carrying the antigenic determinants recog- 
nized by the cross-reactive CTL were studied. In L-929 cells abortively infected with 
fowl plague virus, matrix (M) protein synthesis is specifically inhibited, whereas the 
envelope glycoproteins, hemagglutinin  and  neuraminidase,  are synthesized and  in- 
corporated into the plasma membrane. These target cells were lysed by cross-reactive 
CTL. 
The  envelope proteins  of type A/Victoria  virus  were  separated  from  the  other 956  VIRAL GLYCOPROTEIN  RECOGNITION  BY CROSS-REACTIVE T  CELLS 
virion components  and  reconstituted  into  lipid vesicles that  lacked M  protein that 
subsequently were  used  to prepare artificial target cells. Target-cell formation with 
vesicles was achieved by addition of fusion-active Sendal virus. These artificial target 
cells were also susceptible to lysis by cross-reactive CTL. 
In contrast to previous observations that suggested that the M  protein of influenza 
viruses is recognized by these effector cells, we present evidence that  the antigencic 
determinants induced by the viral glycoproteins are recognized. 
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